KYMERA THERAPEUTICS INC (KYMR) Stock Income Statement
NASDAQ:KYMR - Nasdaq - US5015751044 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 47.07M | 78.59M | 46.83M | 72.83M | 34.03M | |||
| Operating Expenses | 303.78M | 244.12M | 208.08M | 173.36M | 80.34M | |||
| Research and Development | 240.25M | 189.08M | 164.25M | 137.02M | 62.11M | |||
| Selling, General, and Administrative Expenses | 63.53M | 55.04M | 43.83M | 36.35M | 18.23M | |||
| Operating Income | -256.71M | -165.53M | -161.26M | -100.53M | -46.30M | |||
| Interest Income/Expense | 37.78M | 18.57M | 6.45M | 310.00K | 710.00K | |||
| Non Recurring Items | -4.92M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -223.86M | -146.96M | -154.81M | -100.22M | -45.59M | |||
| Net Income | -223.86M | -146.96M | -154.81M | -100.22M | -54.64M | |||
| EBITDA | -249.34M | -161.97M | -158.28M | -98.13M | -44.54M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.98 | -2.52 | -2.87 | -2.09 | -1.23 | |||
| Non GAAP EPS | -2.90 | -2.52 | -2.88 | -2.06 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -475.57% | -186.99% | -330.58% | -137.61% | -160.56% | |||
| Operating Profit Margin | -545.36% | -210.62% | -344.35% | -138.03% | -136.06% | |||
All data in USD